Division of Epidemiology and Biometry, Carl von Ossietzky University, Oldenburg, Germany
Search for other papers by Julia Beckhaus in
Google Scholar
PubMed
Search for other papers by Svenja Boekhoff in
Google Scholar
PubMed
Faculty of Health Sciences and Medicine, University of Lucerne, Lucerne, Switzerland
Department of Pediatrics, McMaster Children’s Hospital and McMaster University, Hamilton, Ontario, Canada
Search for other papers by Katrin Scheinemann in
Google Scholar
PubMed
Search for other papers by Freimut H Schilling in
Google Scholar
PubMed
Search for other papers by Gudrun Fleischhack in
Google Scholar
PubMed
Search for other papers by Gerhard Binder in
Google Scholar
PubMed
Search for other papers by Brigitte Bison in
Google Scholar
PubMed
Search for other papers by Torsten Pietsch in
Google Scholar
PubMed
Search for other papers by Carsten Friedrich in
Google Scholar
PubMed
Search for other papers by Hermann L Müller in
Google Scholar
PubMed
cases of congenital craniopharyngioma (cCP). We analyzed prenatal diagnostic findings, postnatal evaluation, and therapeutic interventions and outcome in these three cases of cCP. Patients and methods Patient cohorts and methods Between 2007
Search for other papers by Annelies van’t Westeinde in
Google Scholar
PubMed
Search for other papers by Leif Karlsson in
Google Scholar
PubMed
Search for other papers by Valeria Messina in
Google Scholar
PubMed
Search for other papers by Lena Wallensteen in
Google Scholar
PubMed
Search for other papers by Manuela Brösamle in
Google Scholar
PubMed
Search for other papers by Giorgio Dal Maso in
Google Scholar
PubMed
Search for other papers by Alessandro Lazzerini in
Google Scholar
PubMed
Search for other papers by Jette Kristensen in
Google Scholar
PubMed
Search for other papers by Diana Kwast in
Google Scholar
PubMed
Search for other papers by Lea Tschaidse in
Google Scholar
PubMed
Search for other papers by Matthias K Auer in
Google Scholar
PubMed
Search for other papers by Hanna F Nowotny in
Google Scholar
PubMed
Department of Endocrine and Metabolic Diseases, Istituto Auxologico Italiano IRCCS, Milan, Italy
Search for other papers by Luca Persani in
Google Scholar
PubMed
Search for other papers by Nicole Reisch in
Google Scholar
PubMed
Search for other papers by Svetlana Lajic in
Google Scholar
PubMed
Introduction Congenital adrenal hyperplasia (CAH) due to 21-hydroxylase (21-OH) deficiency occurs in around 1:10,000–1:15,000 newborns ( 1 , 2 , 3 , 4 , 5 ). It is caused by mutations in the CYP21A2 gene coding for the 21-OH enzyme
Search for other papers by Carmen Sydlik in
Google Scholar
PubMed
Search for other papers by Ilja Dubinski in
Google Scholar
PubMed
Search for other papers by Susanne Bechtold in
Google Scholar
PubMed
Search for other papers by Heinrich Schmidt in
Google Scholar
PubMed
functions and the overall development of the child, the most optimal adjustment of therapy in children with congenital hypothyroidism (cH) seems to be even more important than in adults. There are only a few studies to date that have investigated fT3 levels
Search for other papers by Rachel D C A Diniz in
Google Scholar
PubMed
Search for other papers by Renata M Souza in
Google Scholar
PubMed
Search for other papers by Roberto Salvatori in
Google Scholar
PubMed
Search for other papers by Alex Franca in
Google Scholar
PubMed
Search for other papers by Elenilde Gomes-Santos in
Google Scholar
PubMed
Search for other papers by Thiago O Ferrão in
Google Scholar
PubMed
Search for other papers by Carla R P Oliveira in
Google Scholar
PubMed
Search for other papers by João A M Santana in
Google Scholar
PubMed
Search for other papers by Francisco A Pereira in
Google Scholar
PubMed
Search for other papers by Rita A A Barbosa in
Google Scholar
PubMed
Search for other papers by Anita H O Souza in
Google Scholar
PubMed
Search for other papers by Rossana M C Pereira in
Google Scholar
PubMed
Search for other papers by Alécia A Oliveira-Santos in
Google Scholar
PubMed
Search for other papers by Allysson M P Silva in
Google Scholar
PubMed
Search for other papers by Francisco J Santana-Júnior in
Google Scholar
PubMed
Search for other papers by Eugênia H O Valença in
Google Scholar
PubMed
Search for other papers by Viviane C Campos in
Google Scholar
PubMed
Search for other papers by Manuel H Aguiar-Oliveira in
Google Scholar
PubMed
-binding proteins, mainly IGFBP3. Low serum levels of GH or IGF1 and IGF1/IGFBP3 ratio (reflecting low IGF1 bioavailability) have been hypothesized to contribute to NAFLD in AOGHD (13, 14) . However, congenital (vs acquired) isolated GH deficiency (IGHD
Search for other papers by Marilena Nakaguma in
Google Scholar
PubMed
Search for other papers by Fernanda A Correa in
Google Scholar
PubMed
Search for other papers by Lucas S Santana in
Google Scholar
PubMed
Search for other papers by Anna F F Benedetti in
Google Scholar
PubMed
Search for other papers by Ricardo V Perez in
Google Scholar
PubMed
Search for other papers by Martha K P Huayllas in
Google Scholar
PubMed
Search for other papers by Mirta B Miras in
Google Scholar
PubMed
Search for other papers by Mariana F A Funari in
Google Scholar
PubMed
Search for other papers by Antonio M Lerario in
Google Scholar
PubMed
Search for other papers by Berenice B Mendonca in
Google Scholar
PubMed
Search for other papers by Luciani R S Carvalho in
Google Scholar
PubMed
Search for other papers by Alexander A L Jorge in
Google Scholar
PubMed
Search for other papers by Ivo J P Arnhold in
Google Scholar
PubMed
Introduction Congenital hypopituitarism (CH) is a rare disorder (incidence of 1:3500–10,000 births) defined by the deficiency of one or more pituitary hormones ( 1 , 2 ). Clinical presentation varies, ranging from isolated growth hormone
UPMC Univ, Paris, France
Search for other papers by Anne Bachelot in
Google Scholar
PubMed
Search for other papers by Magaly Vialon in
Google Scholar
PubMed
Search for other papers by Amandine Baptiste in
Google Scholar
PubMed
Search for other papers by Isabelle Tejedor in
Google Scholar
PubMed
Search for other papers by Caroline Elie in
Google Scholar
PubMed
Université Paris Descartes, Paris, France
Search for other papers by Michel Polak in
Google Scholar
PubMed
UPMC Univ, Paris, France
Search for other papers by Philippe Touraine in
Google Scholar
PubMed
Search for other papers by the CRMERC study group in
Google Scholar
PubMed
’ ( 1 ). Congenital adrenal hyperplasia (CAH) is a lifelong condition. CAH is classified according to symptoms, age of presentation and genetics and is usually divided into two forms: the classic or severe form and the non-classic form ( 2 ). Pediatric
Search for other papers by Nikolina Zdraveska in
Google Scholar
PubMed
Search for other papers by Maja Zdravkovska in
Google Scholar
PubMed
Search for other papers by Violeta Anastasovska in
Google Scholar
PubMed
Search for other papers by Elena Sukarova-Angelovska in
Google Scholar
PubMed
Search for other papers by Mirjana Kocova in
Google Scholar
PubMed
Introduction Thyroid hormones play important role in the processes of neuronal migration and differentiation, myelination and synaptogenesis and are essential for proper neurodevelopment ( 1 ). Congenital hypothyroidism (CH) is generally
Search for other papers by Kinnaree Sorapipatcharoen in
Google Scholar
PubMed
Search for other papers by Thipwimol Tim-Aroon in
Google Scholar
PubMed
Search for other papers by Pat Mahachoklertwattana in
Google Scholar
PubMed
Search for other papers by Wasun Chantratita in
Google Scholar
PubMed
Search for other papers by Nareenart Iemwimangsa in
Google Scholar
PubMed
Search for other papers by Insee Sensorn in
Google Scholar
PubMed
Search for other papers by Bhakbhoom Panthan in
Google Scholar
PubMed
Search for other papers by Poramate Jiaranai in
Google Scholar
PubMed
Search for other papers by Saisuda Noojarern in
Google Scholar
PubMed
Search for other papers by Patcharin Khlairit in
Google Scholar
PubMed
Search for other papers by Sarunyu Pongratanakul in
Google Scholar
PubMed
Search for other papers by Chittiwat Suprasongsin in
Google Scholar
PubMed
Search for other papers by Manassawee Korwutthikulrangsri in
Google Scholar
PubMed
Search for other papers by Chutintorn Sriphrapradang in
Google Scholar
PubMed
Search for other papers by Preamrudee Poomthavorn in
Google Scholar
PubMed
Introduction Congenital primary hypothyroidism (CH) is classified into thyroid dysgenesis (TD) and thyroid dyshormonogenesis (TDH) ( 1 ). TDH has increasingly been reported while the incidence of TD has remained stable ( 2 , 3 ). Genetic
Search for other papers by Zi-Di Xu in
Google Scholar
PubMed
Search for other papers by Wei Zhang in
Google Scholar
PubMed
Search for other papers by Min Liu in
Google Scholar
PubMed
Search for other papers by Huan-Min Wang in
Google Scholar
PubMed
Search for other papers by Pei-Pei Hui in
Google Scholar
PubMed
Search for other papers by Xue-Jun Liang in
Google Scholar
PubMed
Search for other papers by Jie Yan in
Google Scholar
PubMed
Search for other papers by Yu-Jun Wu in
Google Scholar
PubMed
Search for other papers by Yan-Mei Sang in
Google Scholar
PubMed
Search for other papers by Cheng Zhu in
Google Scholar
PubMed
Search for other papers by Gui-Chen Ni in
Google Scholar
PubMed
Congenital hyperinsulinism (CHI) is a kind of genetically heterogeneous disease, in which intractable, persistent hypoglycemia is induced by excessive insulin secretion and increased serum insulin concentration ( 1 ). To date, 14 genes ( ABCC8
Search for other papers by Dafydd Aled Rees in
Google Scholar
PubMed
Search for other papers by Deborah P Merke in
Google Scholar
PubMed
Search for other papers by Wiebke Arlt in
Google Scholar
PubMed
Search for other papers by Aude Brac De La Perriere in
Google Scholar
PubMed
Search for other papers by Angelica Linden Hirschberg in
Google Scholar
PubMed
Search for other papers by Anders Juul in
Google Scholar
PubMed
Search for other papers by John Newell-Price in
Google Scholar
PubMed
Search for other papers by Alessandro Prete in
Google Scholar
PubMed
Search for other papers by Nicole Reisch in
Google Scholar
PubMed
Search for other papers by Nike M Stikkelbroeck in
Google Scholar
PubMed
Search for other papers by Philippe A Touraine in
Google Scholar
PubMed
Search for other papers by Alex Lewis in
Google Scholar
PubMed
Search for other papers by John Porter in
Google Scholar
PubMed
Search for other papers by Helen Coope in
Google Scholar
PubMed
Search for other papers by Richard J Ross in
Google Scholar
PubMed
Introduction The control of congenital adrenal hyperplasia (CAH) is suboptimal on standard hydrocortisone replacement therapy because it does not control the overnight rise in adrenocorticotropic hormone (ACTH) that drives the production of